GlassScriptPhysician profile
Jeffrey M Cullers
NPI 1518113471
$313.12
in general payments reported to CMS, 2019-2025
10 companies · $139 in 2025
The $139 reported for 2025 was more than what 80% of Chiropractor providers received nationally (typical 2025 total: $40.91).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $70.71 · 2024: $104 · 2025: $139.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $313.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $64.39 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $55.83 | 2024 | |
| Protega Pharmaceutials INC | $42.50 | 2025 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $32.60 | 2023 | Relistor |
| Vertex Pharmaceuticals Incorporated | $26.00 | 2025 | |
| Genentech USA, INC. | $20.92 | 2025 | Ocrevus Zunovo |
| Livanova USA, INC. | $20.01 | 2023 | Vns Therapy Sentiva Model 1000 Generator |
| Lundbeck LLC | $18.10 | 2023 | Vyepti |
| Pfizer INC. | $17.96 | 2025 | |
| Valinor Pharma, LLC | $14.81 | 2024 | Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Cullers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.